{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T13:09:45Z","timestamp":1781788185966,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82030108"],"award-info":[{"award-number":["82030108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273772"],"award-info":[{"award-number":["82273772"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005089","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7232252"],"award-info":[{"award-number":["7232252"]}],"id":[{"id":"10.13039\/501100005089","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023B1515130008"],"award-info":[{"award-number":["2023B1515130008"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejmech.2025.117621","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T19:15:48Z","timestamp":1744658148000},"page":"117621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Discovery of novel PI3KC2\u03b3 inhibitors with high potency, selectivity, and favorable pharmacokinetics for glycogen metabolism regulation"],"prefix":"10.1016","volume":"291","author":[{"given":"Yi","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peili","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8993-4015","authenticated-orcid":false,"given":"Zhenming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117621_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.117621_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116786","article-title":"From lab to clinic: the discovery and optimization journey of PI3K inhibitors","volume":"277","author":"Lian","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117621_bib3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41580-022-00490-x","article-title":"Phosphoinositides as membrane organizers","volume":"23","author":"Posor","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117621_bib4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1021\/acs.jmedchem.6b00963","article-title":"Class II phosphoinositide 3-Kinases as novel drug targets","volume":"60","author":"Falasca","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117621_bib5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41573-021-00209-1","article-title":"PI3K inhibitors are finally coming of age","volume":"20","author":"Vanhaesebroeck","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117621_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115467","article-title":"Targeting VPS34 in autophagy: an update on pharmacological small-molecule compounds","volume":"256","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117621_bib7","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41590-024-01890-1","article-title":"PI3Kgamma in B cells promotes antibody responses and generation of antibody-secreting cells","volume":"25","author":"Lanahan","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejmech.2025.117621_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41580-019-0129-z","article-title":"PI3K isoforms in cell signalling and vesicle trafficking","volume":"20","author":"Bilanges","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117621_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.adg1913","article-title":"PI3K-C2beta limits mTORC1 signaling and angiogenic growth","volume":"16","author":"Kobialka","year":"2023","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2025.117621_bib10","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41594-022-00730-w","article-title":"Structural basis of phosphatidylinositol 3-kinase C2alpha function","volume":"29","author":"Lo","year":"2022","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.117621_bib11","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1038\/ncomms8400","article-title":"PI3K-C2gamma is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling","volume":"6","author":"Braccini","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117621_bib12","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1074\/jbc.273.13.7731","article-title":"A novel class II phosphoinositide 3-kinase predominantly expressed in the liver and its enhanced expression during liver regeneration","volume":"273","author":"Ono","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117621_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41573-022-00582-5","article-title":"Beyond PI3Ks: targeting phosphoinositide kinases in disease","volume":"22","author":"Burke","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117621_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41572-023-00456-z","article-title":"Glycogen storage diseases","volume":"9","author":"Hannah","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejmech.2025.117621_bib15","article-title":"Enzyme replacement and substrate reduction therapy for gaucher disease","volume":"2015","author":"Shemesh","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejmech.2025.117621_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071065","article-title":"Less is more: substrate reduction therapy for lysosomal storage disorders","volume":"17","author":"Coutinho","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.117621_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1021\/jm5006034","article-title":"Development of first lead structures for phosphoinositide 3-kinase-C2gamma inhibitors","volume":"58","author":"Freitag","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117621_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112556","article-title":"Discovery of 2-(2-aminobenzo[d]thiazol-6-yl) benzo[d]oxazol-5-amine derivatives that regulated HPV relevant cellular pathway and prevented cervical cancer from abnormal proliferation","volume":"204","author":"Jiao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117621_bib19","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1073\/pnas.0908869107","article-title":"MLCK-Dependent exchange and actin binding region-dependent anchoring of ZO-1 regulate tight junction barrier function","volume":"107","author":"Yu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2025.117621_bib20","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1021\/acschembio.4c00336","article-title":"Identification and benchmarking of Myokinasib-II as a selective and potent chemical probe for exploring MLCK1 inhibition","volume":"19","author":"Kumar","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.117621_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.abb.2011.01.017","article-title":"Myosin light chain kinase and the role of myosin light chain phosphorylation in skeletal muscle","volume":"510","author":"Stull","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2025.117621_bib22","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.cellsig.2015.05.013","article-title":"Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: a distinct branch of PI3K signaling","volume":"27","author":"Li","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2025.117621_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1098\/rsob.180147","article-title":"Suitability of hepatocyte cell lines HepG2, AML12 and THLE-2 for investigation of insulin signalling and hepatokine gene expression","volume":"8","author":"Sefried","year":"2018","journal-title":"Open Biol"},{"key":"10.1016\/j.ejmech.2025.117621_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nature12360","article-title":"Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate","volume":"499","author":"Posor","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117621_bib25","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1038\/s41467-021-25341-9","article-title":"Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers","volume":"12","author":"Mao","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117621_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/75651","article-title":"Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking dgat","volume":"25","author":"Smith","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2025.117621_bib27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/dom.12221","article-title":"Diacylglycerol acyltransferase 1 inhibition with AZD7687 alters lipid handling and hormone secretion in the gut with intolerable side effects: a randomized clinical trial","volume":"16","author":"Denison","year":"2014","journal-title":"Diabetes Obes. Metabol."},{"key":"10.1016\/j.ejmech.2025.117621_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.tcb.2019.01.001","article-title":"Class II PI3K functions in cell biology and disease","volume":"29","author":"Gulluni","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2025.117621_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1475-2875-6-169","article-title":"Improved isolation of murine hepatocytes for in vitro malaria liver stage studies","volume":"6","author":"Goncalves","year":"2007","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2025.117621_bib30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s004249900166","article-title":"Effect of the nicotine metabolite 5'-hydroxycotinine on glucose transport and glycogen synthase activity in rat skeletal muscle","volume":"439","author":"Rincon","year":"1999","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.ejmech.2025.117621_bib31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0003-2697(68)90127-9","article-title":"A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose","volume":"25","author":"Thomas","year":"1968","journal-title":"Anal. Biochem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425003861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:46:42Z","timestamp":1778042802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425003861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":31,"alternative-id":["S0223523425003861"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117621","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel PI3KC2\u03b3 inhibitors with high potency, selectivity, and favorable pharmacokinetics for glycogen metabolism regulation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117621"}}